Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Biomedicines|February 25, 2023
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot StudyAlfredo Caturano, Raffaele Galiero, Giuseppe Loffredo, et al.
Biomedicines|December 30, 2020
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, et al.
Biomolecules|February 25, 2022
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in DiabetesTeresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Diabetes/Metabolism Research and Reviews|December 15, 2018
Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter studyFerdinando Carlo Sasso, Pia Clara Pafundi, Aldo Gelso, et al.
International Journal of Molecular Sciences|January 8, 2023
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 DiabetesTeresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomedicines|September 28, 2024
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial CareAlfredo Caturano, Raffaele Galiero, Maria Rocco, et al.
Current Issues in Molecular Biology|August 25, 2023
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle ModificationsAlfredo Caturano, Margherita D'Angelo, Andrea Mormone, et al.
International Journal of Molecular Sciences|April 12, 2022
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 InhibitorsTeresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Diabetes Research and Clinical Practice|July 19, 2021
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidenceAlfredo Caturano, Raffaele Galiero, Pia Clara Pafundi, et al.
Cardiovascular Diabetology|July 17, 2021
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney diseaseFerdinando Carlo Sasso, Pia Clara Pafundi, Vittorio Simeon, et al.
Pageof 7